Blog
RSS FeedPosted by Michael Wonder on 04 May 2021
Australia's TGA grants approval to first objective concussion diagnostic
4 May 2021 - Oculogica's EyeBOX is the only objective diagnostic cleared by the US FDA and Australia TGA as an ...
Posted by Michael Wonder on 03 May 2021
TGA approves key label updates to Buvidal for treatment of opioid dependence
3 May 2021 - Camurus today announced that the Australian regulatory agency, the TGA, has approved key label updates to ...
Posted by Michael Wonder on 26 Apr 2021
Global sarcoma therapy now approved for Australian patients
23 April 2021 - Globally regarded soft tissue sarcoma therapy has been approved by the Therapeutic Goods Administration for Australian patients. ...
Posted by Michael Wonder on 14 Apr 2021
TGA grants provisional determination to GSK for COVID-19 monoclonal antibody treatment - sotrovimab
14 April 2021 - The TGA has granted a provisional determination to GSK in relation to the monoclonal antibody treatment, ...
Posted by Michael Wonder on 08 Apr 2021
Wider storage and transportation conditions for the Pfizer COVID-19 vaccine now approved
8 April 2021 - The Therapeutic Goods Administration has recently approved wider storage and transportation conditions for the Pfizer COVID-19 ...
Posted by Michael Wonder on 24 Mar 2021
Vertex receives Australian TGA approval for Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to treat people with cystic fibrosis ages 12 years and older who have at least one F508del mutation
24 March 2021 - With this approval approximately 750 people living with cystic fibrosis in Australia will be newly eligible for ...
Posted by Michael Wonder on 24 Mar 2021
Super flu vaccine gets the go-ahead
24 March 2021 - A new type of cell-based influenza vaccine is available this winter that promises to be significantly ...
Posted by Michael Wonder on 21 Mar 2021
TGA approves CSL - Seqirus to manufacture AstraZeneca COVID-19 vaccine in Australia
21 March 2021 - Earlier today, the Therapeutic Goods Administration approved manufacture of the AstraZeneca COVID-19 Vaccine (ChAdOx1-S) in Australia. ...
Posted by Michael Wonder on 21 Mar 2021
AstraZeneca vaccine allowed by government regulators to be produced in Australia
21 March 2021 - Astra Zeneca vaccines will be produced in Australia from now on after the regulators approved doses being ...
Posted by Michael Wonder on 14 Mar 2021
Approval of updated storage conditions for the Pfizer COVID-19 vaccine
13 March 2021 - The TGA has received and assessed additional data submitted by Pfizer for their COVID-19 vaccine (COMIRNATY - ...
Posted by Michael Wonder on 10 Mar 2021
Australia’s Therapeutic Goods Administration approves Feraccru to treat iron deficiency with or without anaemia in adults
9 March 2021 - Shield Therapeutics notes that Australia’s Therapeutic Goods Administration has registered Feraccru in the Australian Register of ...
Posted by Michael Wonder on 16 Feb 2021
Medicines Australia statement on TGA’s provisional approval of AstraZeneca’s COVID-19 vaccine
16 February 2021 - Medicines Australia welcomes the TGA’s decision granting provisional approval of the AstraZeneca/Oxford University COVID-19 vaccine, marking ...
Posted by Michael Wonder on 16 Feb 2021
TGA provisionally approves AstraZeneca's COVID-19 vaccine
16 February 2021 - The Therapeutic Goods Administration has granted provisional approval to AstraZeneca for its COVID-19 vaccine, making it ...
Posted by Michael Wonder on 15 Feb 2021
TGA approves new formulation of glatiramer acetate
16 February 2021 - The TGA thinks glatiramer acetate (Glatopa) is a new chemical entity. ...
Posted by Michael Wonder on 02 Feb 2021
Precision medicine helping to change the prognosis of a rare subtype of bowel cancer
2 February 2021 - Australians with a specific type of bowel cancer are no longer subject to a ‘one-size fits ...